Geriatric Dentistry: What do dental clinicians need to know?

Presented by: Dr. Aviv Ouanounou

RCDSO Expiry Date: March 31, 2025

To qualify as a Core Category 1 course, the course certificate must be issued no later than this date.

RCDSO CE Points: 6, Category 1

Points can also be used as Category 2. For further information see our CE Points Page.

Click to close
  • Dr. Aviv Ouanounou BSc, MSc, DDS, FICD, FICO, FACD

    Associate Professor,
    Dept. of Clinical Sciences (Pharmacology)
    University of Toronto, Faculty of Dentistry

    Dr. Aviv Ouanounou is an Associate Professor at the Faculty of Dentistry, University of Toronto. He received both his DDS and MSc at the University of Toronto. He teaches pharmacology to undergraduate and graduate students and is also a clinical instructor and Treatment Plan Coordinator. Dr. Ouanounou won several teaching awards including “Best Teacher of the Year Award” in 2013 and 2015. Also, Dr. Ouanounou is the recipient of the 2014-2015 prestigious Dr. Bruce Hord Master Teacher Award for excellence in teaching at the Faculty of Dentistry at the University of Toronto. He is a member of the American Academy of Pain Management and the American College of Clinical Pharmacology. He also maintains a general private practice in Toronto.

Current Status
Not Enrolled
Get Started

Current demographic data clearly show that the North American population is aging, and projections suggest that the percentage of older people will increase. The elderly often suffer from multiple chronic conditions that affect their quality of life, use of health services, morbidity and mortality. Also, in those of advanced age, the pharmacokinetics and pharmacodynamics of many drugs are altered. Thus, the dental practitioner must be continually aware of the pharmacologic status of each patient and consider the likelihood of interactions between drugs prescribed by the dentist, drugs prescribed by the physician and drugs that are self-administered, including over-the-counter medications and natural supplements. In this lecture, we will discuss pharmacokinetic and pharmacodynamic changes in the elderly patient, polypharmacy, various comorbidities and the changes in prescribing for our dental patients. Also, we will review preventive strategies in this population.

Learning Objectives:

1. Understand the shift in demographics and challenges to dental practice.

2. Understand the effects the implications of aging on pharmacokinetics and pharmacodynamics.

3. Define poly-pharmacy and recognize it in daily practice.

4. Recognize common comorbidities in the elderly and common adverse drug reactions and Drug Interactions.

5. Discuss the Preventive strategies in the geriatric population.